YCM
MRNA icon

Yousif Capital Management’s Moderna MRNA Stock Holding History

Yousif Capital Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.86M Sell
40,868
-2,113
-5% -$109K 0.03% 526
2026
Q1 		$2.18M Sell
42,981
-3,358
-7% -$157K 0.03% 621
2025
Q4 		$1.99M Sell
46,339
-751
-2% -$20.4K 0.02% 706
2025
Q3 		$1.22M Buy
47,090
+2,234
+5% +$62.3K 0.01% 994
2025
Q2 		$1.24M Buy
44,856
+2,888
+7% +$76.1K 0.01% 1012
2025
Q1 		$1.19M Sell
41,968
-203
-0.5% -$7.2K 0.01% 1014
2024
Q4 		$1.75M Buy
42,171
+1,568
+4% +$74.9K 0.02% 831
2024
Q3 		$2.71M Buy
40,603
+1,068
+3% +$98.1K 0.03% 594
2024
Q2 		$4.69M Buy
39,535
+616
+2% +$78K 0.05% 346
2024
Q1 		$4.15M Sell
38,919
-381
-1% -$38.4K 0.05% 422
2023
Q4 		$3.91M Sell
39,300
-4,130
-10% -$347K 0.05% 420
2023
Q3 		$4.49M Sell
43,430
-670
-2% -$74.7K 0.06% 341
2023
Q2 		$5.36M Buy
44,100
+958
+2% +$128K 0.07% 296
2023
Q1 		$6.63M Sell
43,142
-7,077
-14% -$1.17M 0.09% 220
2022
Q4 		$9.02M Sell
50,219
-2,951
-6% -$483K 0.12% 173
2022
Q3 		$6.29M Sell
53,170
-1,707
-3% -$259K 0.09% 214
2022
Q2 		$7.84M Buy
54,877
+395
+0.7% +$56.5K 0.1% 192
2022
Q1 		$9.38M Buy
54,482
+67
+0.1% +$11.3K 0.1% 186
2021
Q4 		$13.8M Buy
+54,415
New +$15.9M 0.14% 122

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Yousif Capital Management's MRNA Position: Q2 2026 in Review

Yousif Capital Management reduced its Moderna (MRNA) stake by 4.9% in Q2 2026, selling an estimated $109K and leaving 40,868 shares worth $2.86M. The position accounts for 0.03% of the portfolio, ranked #526.

Yousif Capital Management first reported a position in MRNA in Q4 2021 and has held it in 19 quarters since. The position peaked at $13.8M in Q4 2021. 784 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Yousif Capital Management held 40,868 shares of Moderna worth $2.86M as of Q2 2026.
  • Yousif Capital Management sold 2,113 Moderna shares in Q2 2026, an estimated $109K.
  • Moderna made up 0.03% of Yousif Capital Management's portfolio in Q2 2026, its #526 holding.
  • Yousif Capital Management first reported a position in Moderna in Q4 2021 and has held it in 19 quarters since.
  • Yousif Capital Management's Moderna position peaked at $13.8M in Q4 2021.
  • 784 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Yousif Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.